Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound

Details for Australian Patent Application No. 2005300313 (hide)

Owner Glenmark Pharmaceuticals Limited

Inventors Chaudhari, G. N.; Bhamre, N. B.; Khachane, V. S.; Macharla, Jagannath

Agent Fisher Adams Kelly

Pub. Number AU-B-2005300313

PCT Pub. Number WO2006/048747

Priority 60/625,872 08.11.04 US

Filing date 8 November 2005

Wipo publication date 11 May 2006

Acceptance publication date 26 May 2011

International Classifications

A61K 31/07 (2006.01)

A61K 31/7048 (2006.01)

A61P 17/10 (2006.01) Drugs for dermatological disorders

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/048747 Priority application(s): WO2006/048747

26 May 2011 Application Accepted

  Published as AU-B-2005300313

22 September 2011 Standard Patent Sealed

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300315-CTLA-4 antibody and aromatase inhibitor or combination treatment for breast cancer

2005300311-Methods for preparing indazole compounds